Dartmouth Labs Put COVID-19 Research on the Fast Track
A coalition of scientists are working around the clock to improve testing and develop new therapies.
A coalition of scientists are working around the clock to improve testing and develop new therapies.
The CEO and president of Dartmouth-Hitchcock will speak about health care innovation.
Experts will highlight cutting-edge social, cognitive, and neuroscientific scholarship.
Leach, a physician and scientist, will begin work at the center in September.
Physician and Dartmouth alumna Joanne Mather Conroy ’77 has been named chief executive officer and president of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health, announced D-H Board of Trustees Chair Anne-Lee Verville.
The professorship in palliative medicine is named for Dorothy and John J. Byrne Jr.
James Weinstein will remain in the role of CEO and president until the end of June 2017.
The six-week Osher series will examine the future of health care.
The Geisel School of Medicine and Dartmouth-Hitchcock health system (D-H) have embarked on a linked restructuring process that builds on a commitment to align their clinical, educational, and research activities.
Faculty and staff at the Geisel School of Medicine today learned that they would be notified within the next several weeks about potential changes in their employment status as a result of reorganization of the medical school.